Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Boehringer seeks real-world data to support reversal agent
BioPharma Dive
Thu, 08/18/16 - 08:49 am
Tags:
Boehringer Ingelheim, Praxbind, Pradaxa, anticoagulants, anticoagulant reversal
Boehringer strikes deal to develop protein degrading cancer drugs
Fierce Biotech
Thu, 07/14/16 - 09:14 am
Tags:
Boehringer Ingelheim, R&D, cancer, PROTACs
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Yahoo
Wed, 07/13/16 - 09:46 am
Tags:
Eli Lilly, Boehringer Ingelheim, clinical trials, metastatic breast cancer, abemaciclib, BI 836845
Boehringer slashes 724 jobs off U.S. sales payroll to boost R&D spending
Fierce Pharma
Fri, 07/1/16 - 09:38 am
Tags:
Boehringer Ingelheim, layoffs, drug reps
U.S. panel backs claim Lilly diabetes drug cuts cardiac death
Yahoo/Reuters
Tue, 06/28/16 - 10:55 pm
Tags:
FDA, advisory panels, Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes
How the Asset Swap Deal Fits into Sanofi’s Restructuring Plans
Bidness, ETC
Mon, 06/27/16 - 03:05 pm
Tags:
Sanofi, Merial, animal health, restructuring, Boehringer Ingelheim
Sanofi to Exit Animal Care in $25 Billion Asset Swap With Boehringer
TheStreet.com
Mon, 06/27/16 - 09:42 am
Tags:
Sanofi, animal health, Boehringer Ingelheim, Merial
FDA panel to vote whether diabetes drug cuts cardiac death
Yahoo/Reuters
Fri, 06/24/16 - 04:06 pm
Tags:
FDA, advisory panels, diabetes, Eli Lilly, Boehringer Ingelheim, Jardiance
Lilly and Boehringer's Jardiance sets new bar, shows kidney benefit
BioPharma Dive
Wed, 06/15/16 - 05:42 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes, kidney disease
New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes
Yahoo
Sun, 06/12/16 - 09:56 pm
Tags:
type 2 diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim
Boehringer Ingelheim launches gamified support program
Medical Marketing and Media
Wed, 06/8/16 - 09:28 pm
Tags:
Boehringer Ingelheim, Spiriva Respimat, COPD, customer support
The Little-Known Reason Arena Pharmaceuticals Could Be a Winner
Motley Fool
Wed, 06/1/16 - 04:49 pm
Tags:
Arena Pharmaceuticals, Belviq, CNS, Boehringer Ingelheim
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
Investors.com
Tue, 05/24/16 - 11:54 pm
Tags:
AbbVie, Crohn's Disease, risankizumab, Boehringer Ingelheim
Interview – Boehringer’s new look aims to boost innovation
EP Vantage
Wed, 04/27/16 - 02:41 pm
Tags:
R&D, Boehringer Ingelheim, biotech, diabetes
Boehringer sees turbocharged diabetes unit driving future growth
Fierce Pharma
Mon, 04/25/16 - 10:06 am
Tags:
Boehringer Ingelheim, diabetes
Eli Lilly’s Jardiance Can be a Threat to Novartis’ Entresto
Bidness, ETC
Wed, 04/20/16 - 09:46 pm
Tags:
Eli Lilly, Jardiance, Novartis, Entresto, Boehringer Ingelheim, diabetes, heart failure
Eli Lilly And Boehringer Reveals Study On Jardiance For Treatment Heart Failure
Yahoo/Benzinga
Tue, 04/19/16 - 09:47 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes, chronic heart failure
Boehringer's operating profit up 6 percent on diabetes drugs
Yahoo/Reuters
Tue, 04/19/16 - 09:33 am
Tags:
Boehringer Ingelheim, earnings
ACC 2016: Boehringer's Pradaxa 'antidote' passes real-world test
BioPharma Dive
Tue, 04/5/16 - 08:49 am
Tags:
Boehringer Ingelheim, Pradaxa, Praxbind
What Abbvie’s Latest Deal Means For The Company
Bidness, ETC
Tue, 03/8/16 - 06:13 pm
Tags:
AbbVie, R&D, Boehringer Ingelheim

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.